shaw patterns of resistance in alk positive nsclc
Published 6 years ago • 2.6K plays • Length 6:02Download video MP4
Download video MP3
Similar videos
-
4:31
alk-positive nsclc: alex trial
-
2:51
highlights on adjuvant alectinib in early alk positive nsclc: the alina study
-
6:19
stage 3 unresectable nsclc
-
1:39
key findings of the alex study: improved therapeutic options for alk-positive nsclc
-
1:35
dr. shaw on the phase iii results of the alex trial in nsclc
-
20:58
how to treat small cell lung cancer using treatment algorithm with dr. eric singhi
-
4:09
the pathophysiology of non-small cell lung cancer
-
5:41
understanding nsclc treatments for less common mutations: alk, braf, ros1, her2, met
-
2:42
what is stage iii unresectable nsclc?
-
0:35
current standard of care for inoperable stage iii nsclc
-
24:20
how to treat early stage non-small cell lung cancer
-
5:29
the role of driver mutations in nsclc treatment - 2022 program: lcvl
-
6:05
treatment and management of non-small cell lung cancer (nsclc)
-
2:13
lung cancer video library - immunotherapy in stage lll nsclc - the pacific trial and imfinzi
-
16:10
lung cancer esmo 2024 highlights: key studies discussed laura, mariposa, mariposa-2, adriatic
-
0:37
alina: evaluating the safety of adjuvant alectinib for alk nsclc
-
7:13
what are the options: lung cancer & non-small cell lung cancer (nsclc)
-
4:34
case based panel discussion - stage 3 nsclc treatment standard and the risk of potential pneumonitis
-
26:14
how to treat non-small cell lung cancer with actionable mutations with dr. balazs halmos
-
1:16
dr. alexander spira discusses advances in non-small cell lung cancer (nsclc)
-
7:44
asco lung cancer highlights, part 1: introduction to stage iii nsclc
-
2:28
akkermansia muciniphila as a biomarker for ici response in nsclc